BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 8212991)

  • 21. Hypothalamus-pituitary-ovarian axis in cyclic rats lacking progesterone actions.
    Sánchez-Criado JE; Galiot F; Bellido C; Gonzalez D; Tébar M
    Biol Reprod; 1993 Apr; 48(4):916-25. PubMed ID: 8485257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoregulation of the gonadotropin-releasing hormone (GnRH) system during puberty: effects of antagonistic versus agonistic GnRH analogs in a female rat model.
    Roth C; Schricker M; Lakomek M; Strege A; Heiden I; Luft H; Munzel U; Wuttke W; Jarry H
    J Endocrinol; 2001 May; 169(2):361-71. PubMed ID: 11312152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of the gonadotrophin surge-inhibiting factor by FSH and its elimination: a sex difference in the efficacy of the priming effect of gonadotrophin-releasing hormone on the rat pituitary gland.
    Koppenaal DW; van Dieten JA; Tijssen AM; de Koning J
    J Endocrinol; 1993 Aug; 138(2):191-201. PubMed ID: 8228727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tamoxifen but not other selective estrogen receptor modulators antagonizes estrogen actions on luteinizing hormone secretion while inducing gonadotropin-releasing hormone self-priming in the rat.
    Sánchez-Criado JE; Guelmes P; Bellido C; Gónzalez M; Hernández G; Aguilar R; Garrido-Gracia JC; Bello AR; Alonso R
    Neuroendocrinology; 2002 Oct; 76(4):203-13. PubMed ID: 12411737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in pituitary secretion during the early postnatal period and anovulatory syndrome induced by neonatal oestrogen or androgen in rats.
    Pinilla L; Trimiño E; Garnelo P; Bellido C; Aguilar R; Gaytán F; Aguilar E
    J Reprod Fertil; 1993 Jan; 97(1):13-20. PubMed ID: 8464003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of a novel gonadotropin-releasing hormone antagonist (ORG 30850) on gonadotropin and prolactin secretion by rat pituitary cells in culture.
    Franchimont P; Almer SM; Charlet-Renard CJ; Daubresse CL; Kicovic PP
    Acta Endocrinol (Copenh); 1991 Jan; 124(1):98-106. PubMed ID: 1900380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of suckling on pituitary responsiveness to gonadotropin-releasing hormone throughout the early postpartum period of beef cows.
    Williams GL; Kotwica J; Slanger WD; Olson DK; Tilton JE; Johnson LJ
    J Anim Sci; 1982 Mar; 54(3):594-602. PubMed ID: 6806232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Active immunization of gilts against gonadotropin-releasing hormone: effects on secretion of gonadotropins, reproductive function, and responses to agonists of gonadotropin-releasing hormone.
    Esbenshade KL; Britt JH
    Biol Reprod; 1985 Oct; 33(3):569-77. PubMed ID: 2932169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential regulation of luteinizing hormone, follicle-stimulating hormone, and free alpha-subunit secretion from the gonadotrope by gonadotropin-releasing hormone (GnRH): evidence from the use of two GnRH antagonists.
    Hall JE; Whitcomb RW; Rivier JE; Vale WW; Crowley WF
    J Clin Endocrinol Metab; 1990 Feb; 70(2):328-35. PubMed ID: 2105329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men.
    Pavlou SN; Wakefield G; Schlechter NL; Lindner J; Souza KH; Kamilaris TC; Konidaris S; Rivier JE; Vale WW; Toglia M
    J Clin Endocrinol Metab; 1989 Feb; 68(2):446-54. PubMed ID: 2537334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gonadotropin gene expression and secretion in gonadotropin-releasing hormone antagonist-treated male rats: effect of sex steroid replacement.
    Perheentupa A; Huhtaniemi I
    Endocrinology; 1990 Jun; 126(6):3204-9. PubMed ID: 1693570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulsatile administration of gonadotropin-releasing hormone agonist to gilts actively immunized against gonadotropin-releasing hormone.
    Traywick GB; Esbenshade KL
    J Anim Sci; 1988 Sep; 66(9):2209-15. PubMed ID: 3139608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
    de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of postnatal treatment with a gonadotropin-releasing hormone antagonist on sexual maturation of male rats.
    Huhtaniemi IT; Nevo N; Amsterdam A; Naor Z
    Biol Reprod; 1986 Oct; 35(3):501-7. PubMed ID: 3098312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of estrogen and follicle-stimulating hormone on basal and luteinizing hormone (LH)-releasing hormone-stimulated LH secretion in RU-486-induced 3-day estrous cycle in the rat.
    Tébar M; Ruiz A; Sánchez-Criado JE
    Biol Reprod; 1998 Feb; 58(2):615-9. PubMed ID: 9475421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms for altered reproductive function in female rats following neonatal administration of raloxifene.
    Tena-Sempere M; Barreiro ML; Aguilar E; Pinilla L
    Eur J Endocrinol; 2004 Mar; 150(3):397-403. PubMed ID: 15012627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potent pituitary-gonadal axis suppression and extremely low anaphylactoid activity of a new gonadotropin releasing hormone (GnRH) receptor antagonist "azaline B".
    Campen CA; Lai MT; Kraft P; Kirchner T; Phillips A; Hahn DW; Rivier J
    Biochem Pharmacol; 1995 May; 49(9):1313-21. PubMed ID: 7763313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of gonadotropin-releasing hormone antagonists on serum follicle-stimulating hormone and luteinizing hormone under conditions of singular follicle-stimulating hormone secretion.
    Schwartz NB; Rivier C; Rivier J; Vale WW
    Biol Reprod; 1985 Mar; 32(2):391-8. PubMed ID: 3921074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pituitary-testicular function in immature rats after treatment with GnRH antagonist, GnRH antiserum and bromocriptine.
    Huhtaniemi IT; Stewart JM; Channabasavaiah K; Fraser HM; Clayton RN
    Mol Cell Endocrinol; 1984 Feb; 34(2):137-43. PubMed ID: 6325270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.